Stockreport

NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings Estimates [Yahoo! Finance]

NRX Pharmaceuticals, Inc.  (NRXP) 
PDF This compares to a loss of $0.3 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +323 [Read more]